Belgium's Gimv sells remaining Ablynx stake
BRUSSELS Oct 17 (Reuters) - Belgian investment fund Gimv said it sold its remaining stake in biotech firm Ablynx after partnering the company for 12 years.
Gimv said the exit has a positive impact of 3.8 million euros on its last published equity value, and it would use the proceeds to make other investments in the biotech sector. (Reporting by Robert-Jan Bartunek)
- Malaysian plane presumed crashed; questions over false IDs |
- China draws 'red line' on North Korea, says won't allow war on peninsula
- Warning shots fired to turn monitors back from Crimea |
- Libya threatens to bomb North Korean tanker if it ships oil from rebel port